http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-8103098-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-30
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-345
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-59
filingDate 1980-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1981-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-8103098-A1
titleOfInvention A PROCEDURE FOR PREPARING A CEPHALOSPORIN SOLVATE
abstract PROCEDURE FOR OBTAINING A CEPHALOSPORIN SOLVATE FROM THE FORMULA: * FORMULA * IN THE <<N>> VALUE 1 OR 0; WHERE X IS ETHANOCIUM, PROPANOIC OR METHANOL WHEN <<N>> IS 0. THE OBTAINING PROCEDURE IS BASED ON CONTACT WITH A 4 '' 7-PHENOXYACETAMIC-3-HYDROXY-3-CEFEM-CARBOXYLATE SULFIDE - NITROBENZYL OR A SULFOXIDE THEREOF WITH ACETIC OR PROPIONIC ACID IN THE PRESENCE, OPTIONAL, OF A SOLVENT. SUBSEQUENTLY, A METHYLENE CHLORIDE SOLVATE IS CRYSTALIZED, WHICH IS SEPARABLE BY FILTRATION. THESE COMPOUNDS ARE USED IN MEDICINE AS ANTIBIOTICS. B
priorityDate 1979-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8442
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407126721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414863366

Total number of triples: 37.